Continuous Femoral Block With Levobupivacaine 0.125% or Ropivacaine 0.2% in Elderly Patients With Femoral Fractures
Condition(s):Femur Fracture; Hip FracturesLast Updated:February 20, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Femur Fracture; Hip FracturesLast Updated:February 20, 2020Unknown status
Condition(s):Femoral Nerve Block; Amputation of KneeLast Updated:July 7, 2023Recruiting
Condition(s):POSTOPERATIVE ANALGESIA FOR TKA PARECOXIB/CFBLast Updated:July 10, 2014Completed
Condition(s):Knee Surgery; Postoperative PainLast Updated:August 1, 2017Completed
Condition(s):Total Hip Replacement SurgeryLast Updated:December 11, 2018Unknown status
Condition(s):Total Knee ReplacementLast Updated:February 28, 2011Completed
Condition(s):Total Knee ArthroplastyLast Updated:August 3, 2016Completed
Condition(s):Peripheral Nerve InjuryLast Updated:March 15, 2012Unknown status
Condition(s):Diabetic FootLast Updated:April 4, 2016Completed
Condition(s):PAINLast Updated:May 3, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.